|
Volumn 44, Issue 6, 2003, Pages 1081-1082
|
99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEXAMETHASONE;
MELPHALAN;
METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;
THALIDOMIDE;
TRACER;
ADULT;
AGED;
AUTOLOGOUS BONE MARROW TRANSPLANTATION;
BIOACCUMULATION;
BLOOD ANALYSIS;
CANCER RECURRENCE;
CANCER SCINTISCANNING;
CELL INFILTRATION;
CLINICAL ARTICLE;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG UPTAKE;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LETTER;
MALE;
MULTIPLE MYELOMA;
MYELOMA CELL;
NEUROTOXICITY;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
SCORING SYSTEM;
URINALYSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
BONE MARROW;
DEXAMETHASONE;
FEMALE;
HUMANS;
MALE;
MELPHALAN;
MIDDLE AGED;
MULTIPLE MYELOMA;
RADIOPHARMACEUTICALS;
TECHNETIUM TC 99M SESTAMIBI;
THALIDOMIDE;
TISSUE DISTRIBUTION;
|
EID: 0037409907
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/1042819031000077115 Document Type: Letter |
Times cited : (3)
|
References (6)
|